GlobeNewswire Inc.··Not SpecifiedImmuron Posts Double-Digit Q3 Growth as Travelan® Expands Globally
Immuron reports Q3 sales of AUD$1.5M, up 16% YoY, with explosive 82% growth in Canada offsetting modest USA expansion.
IMRNsales growthbiopharmaceutical